|
시장보고서
상품코드
1566354
세계의 T4 DNA 리가아제 시장 : 규모, 점유율, 동향, 산업 분석 보고서 - 유형별, 용도별, 지역별 시장 예측(2024-2032년)T4 DNA Ligase Market Size, Share, Trends, Industry Analysis Report: By Type (1 U/μL, 5 U/μL), By Application, and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2024 - 2032 |
||||||
Polaris Market Research의 최신 조사에 따르면 세계 T4 DNA 리가아제 시장 규모는 2032년까지 2억 2,357만 달러에 이를 것으로 예상됩니다. 이 설문조사 보고서는 현재 시장 역학을 자세히 파악하고 미래 시장 성장에 대한 분석을 제공합니다.
T4 DNA 리가아제 시장은 분자 생물학과 생명공학 연구의 진보로 큰 성장을 이루고 있습니다. DNA 조작과 클로닝에 필수적인 이 효소는 유전자 공학, 합성 생물학, 유전체학에서 매우 중요한 역할을 합니다. 이러한 분야가 진화를 계속하고 있는 가운데 유전자 치료에 초점을 맞춘 연구 프로젝트 증가와 맞춤형 의료에 대한 관심 증가에 힘입어 T4 DNA 리가아제 수요가 급증하고 있습니다. DNA 단편을 효율적으로 결합시키는 효소의 능력은 유전자 편집, DNA 염기 시퀀싱, 합성 생물학을 포함한 다양한 용도에 필수적입니다.
게다가 시장의 주요 동향으로는 신규 리가아제 제제의 개발과 효소 성능의 향상을 들 수 있으며, 이에 따라 응용 범위가 확대되어 전체적인 효율이 향상되고 있습니다. 연구개발에 대한 지속적인 투자는 효소 기술 혁신에 박차를 가하고 시장 성장을 더욱 촉진하고 있습니다. 맞춤형 의료의 인기 증가와 바이오 기술 혁신의 진보가 함께, T4 DNA 리가아제 분야에는 사업 확대의 기회가 풍부하게 태어날 것으로 기대되고 있습니다. 과학계가 유전자 연구와 치료 응용의 한계를 밀어 펼치고 있는 가운데, T4 DNA 리가아제 시장은 대폭적이고 지속적인 성장을 이루는 태세가 갖추어지고 있습니다.
T4 DNA 리가아제 시장 보고서 하이라이트
1U/μL T4 DNA 리가아제는 비용 효율성과 효율성 때문에 표준 분자 생물학 응용 분야에서 널리 사용되기 때문에 지배적인 부문이 되었습니다. 5U/μL 유형도 보다 고농도의 효소를 필요로 하는 특수한 용도로 지지를 모으고 있어 급속한 성장에 기여하고 있습니다.
과학 연구 부문은 학술 및 산업 연구실에서 광범위한 사용으로 시장을 선도하고 있습니다. 또한 유전체 연구 및 새로운 치료법 개발에 대한 투자 증가를 반영하여 의약품과 백신의 R&D 용도가 가장 높은 성장률을 보였습니다.
생명공학의 발전과 첨단 연구 인프라가 북미를 시장의 주요 지역으로 삼고 있습니다. 아시아태평양은 연구활동 확대, 생명공학 투자 증가, 제약·의료분야의 급속한 발전을 배경으로 가장 성장하고 있는 지역입니다.
목차
제1장 서론
제2장 주요 요약
제3장 조사 방법
제4장 세계의 T4 DNA 리가아제 시장 인사이트
- 시장 현황
- T4 DNA 리가아제 시장 역학
- 성장 촉진요인과 기회
- 합성 생물학 용도의 성장이 시장의 성장을 견인
- 맞춤형 의료에 대한 주목의 고조가 시장의 성장을 견인
- 억제요인과 과제
- 효소와 키트의 고비용이 시장 성장을 억제
- 성장 촉진요인과 기회
- PESTEL 분석
- T4 DNA 리가아제 시장의 응용 동향
- 밸류체인 분석
- COVID-19의 영향 분석
제5장 세계의 T4 DNA 리가아제 시장 : 유형별
- 주요 조사 결과
- 소개
- 1U/μL
- 5U/μL
제6장 세계의 T4 DNA 리가아제 시장 : 용도별
- 주요 조사 결과
- 소개
- 과학조사
- 의약품과 백신의 연구개발
- 클론 실험
- 기타
제7장 세계의 T4 DNA 리가아제 시장 : 지역별
- 주요 조사 결과
- 소개
- T4 DNA 리가아제 시장 평가:지역별, 2019-2032년
- 북미
- 북미 : 유형별, 2019-2032년
- 북미 : 용도별, 2019-2032년
- 미국
- 캐나다
- 유럽
- 유럽 : 유형별, 2019-2032년
- 유럽 : 용도별, 2019-2032년
- 영국
- 프랑스
- 독일
- 이탈리아
- 스페인
- 네덜란드
- 러시아
- 기타 유럽
- 아시아태평양
- 아시아태평양: 유형별, 2019-2032년
- 아시아태평양: 용도별, 2019-2032년
- 중국
- 인도
- 말레이시아
- 일본
- 인도네시아
- 한국
- 호주
- 기타 아시아태평양
- 중동 및 아프리카
- 중동 및 아프리카 : 유형별, 2019-2032년
- 중동 및 아프리카 : 용도별, 2019-2032년
- 사우디아라비아
- 아랍에미리트(UAE)
- 이스라엘
- 남아프리카
- 기타 중동 및 아프리카
- 라틴아메리카
- 라틴아메리카 : 유형별, 2019-2032년
- 라틴아메리카: 용도별, 2019-2032년
- 멕시코
- 브라질
- 아르헨티나
- 기타 라틴아메리카
제8장 경쟁 구도
- 확대와 인수 분석
- 확대
- 인수
- 제휴/협업/합의/공개
제9장 기업 프로파일
- Thermo Fisher Scientific
- New England Biolabs
- Merck KGaA
- Promega Corporation
- Takara Bio Inc.
- Agilent Technologies
- Roche Diagnostics
- Qiagen NV
- Bio-Rad Laboratories
- Illumina Inc.
- GenScript Biotech Corporation
- Lucigen Corporation
- Eurofins Scientific
- Jena Bioscience.
- Bioline.
The global T4 DNA ligase market size is expected to reach USD 223.57 million by 2032, according to a new study by Polaris Market Research. The report "T4 DNA Ligase Market Size, Share, Trends, Industry Analysis Report: By Type (1 U/μL, 5 U/μL), By Application, and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2024 - 2032" gives a detailed insight into current market dynamics and provides an analysis of future market growth.
The T4 DNA ligase market is experiencing significant growth driven by advancements in molecular biology and biotechnology research. This enzyme, crucial for DNA manipulation and cloning, plays a pivotal role in genetic engineering, synthetic biology, and genomics. As these fields continue to evolve, the demand for T4 DNA ligase has surged, supported by the increasing number of gene therapy-focused research projects and the rising interest in personalized medicine. The enzyme's ability to join DNA fragments efficiently makes it essential for various applications, including gene editing, DNA sequencing, and synthetic biology.
Moreover, key trends within the market highlight the development of novel ligase formulations and enhanced enzyme performance, which are expanding its application range and improving overall efficiency. Ongoing investments in research and development are fueling innovations in enzyme technology, further driving market growth. The growing popularity of customized medicine, coupled with advancements in biotechnological innovations, is expected to create ample opportunities for business expansion in the T4 DNA ligase sector. As the scientific community continues to push the boundaries of genetic research and therapeutic applications, the T4 DNA ligase market is poised for substantial and sustained growth.
T4 DNA Ligase Market Report Highlights:
The 1 U/μL T4 DNA ligase is the dominant segment, owing to its widespread use in standard molecular biology applications due to its cost-effectiveness and efficiency. The 5 U/μL type is also gaining traction for specialized applications requiring higher enzyme concentrations, contributing to its rapid growth.
The scientific research segment leads the market, driven by extensive use in academic and industrial research laboratories. Additionally, the medicine and vaccine R&D application is the highest growing segment, reflecting increasing investments in genomic research and development of new therapies.
The highly adopted biotechnological advances and advanced research infrastructure drive North America as the leading region in the market. Asia Pacific is the highest growing region, driven by expanding research activities, increasing biotechnology investments, and rapid development in the pharmaceutical and medical sectors.
Polaris Market Research has segmented the T4 DNA Ligase market report based on type, application, and region
T4 DNA Ligase Market - Type Outlook (Revenue - USD million, 2019 - 2032)
- 1 U/μL
- 5 U/μL
T4 DNA Ligase Market - Application Outlook (Revenue - USD million, 2019 - 2032)
- Scientific Research
- Medicine and Vaccine R&D
- Cloning Experiment
- Others
T4 DNA Ligase Market - Regional Outlook (Revenue - USD million, 2019 - 2032)
- North America
- US
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Netherlands
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Malaysia
- South Korea
- Indonesia
- Australia
- Vietnam
- Rest of Asia Pacific
- Middle East & Africa
- Saudi Arabia
- UAE
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Mexico
- Brazil
- Argentina
- Rest of Latin America
Table of Contents
1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
2. Executive Summary
- 2.1. Market Highlights
3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
4. Global T4 DNA Ligase Market Insights
- 4.1. T4 DNA Ligase Market - Market Snapshot
- 4.2. T4 DNA Ligase Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Growth in Synthetic Biology Applications Are Driving Market Growth
- 4.2.1.2. Increasing Focus on Personalized Medicine Are Driving the Market Growth
- 4.2.2. Restraints and Challenges
- 4.2.2.1. High Costs of Enzymes and Kits Hinders the Market Growth
- 4.2.1. Drivers and Opportunities
- 4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTEL Analysis
- 4.5. T4 DNA Ligase Market Application Trends
- 4.6. Value Chain Analysis
- 4.7. COVID-19 Impact Analysis
5. Global T4 DNA Ligase Market, by Type
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global T4 DNA Ligase Market, by Type, 2019-2032 (USD million)
- 5.3. 1 U/μL
- 5.3.1. Global T4 DNA Ligase Market, by 1 U/μL, by Region, 2019-2032 (USD million)
- 5.4. 5 U/μL
- 5.4.1. Global T4 DNA Ligase Market, by 5 U/μL, by Region, 2019-2032 (USD million)
6. Global T4 DNA Ligase Market, by Application
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global T4 DNA Ligase Market, by Application, 2019-2032 (USD million)
- 6.3. Scientific Research
- 6.3.1. Global T4 DNA Ligase Market, by Scientific Research, by Region, 2019-2032 (USD million)
- 6.4. Medicine and Vaccine R&D
- 6.4.1. Global T4 DNA Ligase Market, by Medicine and Vaccine R&D, by Region, 2019-2032 (USD million)
- 6.5. Cloning Experiment
- 6.5.1. Global T4 DNA Ligase Market, by Cloning Experiment, by Region, 2019-2032 (USD million)
- 6.6. Others
- 6.6.1. Global T4 DNA Ligase Market, by Others, by Region, 2019-2032 (USD million)
7. Global T4 DNA Ligase Market, by Geography
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. T4 DNA Ligase Market Assessment, By Geography, 2019-2032 (USD million)
- 7.3. T4 DNA Ligase Market - North America
- 7.3.1. North America: T4 DNA Ligase Market, by Type, 2019-2032 (USD million)
- 7.3.2. North America: T4 DNA Ligase Market, by Application, 2019-2032 (USD million)
- 7.3.3. T4 DNA Ligase Market - U.S.
- 7.3.3.1. U.S.: T4 DNA Ligase Market, by Type, 2019-2032 (USD million)
- 7.3.3.2. U.S.: T4 DNA Ligase Market, by Application, 2019-2032 (USD million)
- 7.3.4. T4 DNA Ligase Market - Canada
- 7.3.4.1. Canada: T4 DNA Ligase Market, by Type, 2019-2032 (USD million)
- 7.3.4.2. Canada: T4 DNA Ligase Market, by Application, 2019-2032 (USD million)
- 7.4. T4 DNA Ligase Market - Europe
- 7.4.1. Europe: T4 DNA Ligase Market, by Type, 2019-2032 (USD million)
- 7.4.2. Europe: T4 DNA Ligase Market, by Application, 2019-2032 (USD million)
- 7.4.3. T4 DNA Ligase Market - UK
- 7.4.3.1. UK: T4 DNA Ligase Market, by Type, 2019-2032 (USD million)
- 7.4.3.2. UK: T4 DNA Ligase Market, by Application, 2019-2032 (USD million)
- 7.4.4. T4 DNA Ligase Market - France
- 7.4.4.1. France: T4 DNA Ligase Market, by Type, 2019-2032 (USD million)
- 7.4.4.2. France: T4 DNA Ligase Market, by Application, 2019-2032 (USD million)
- 7.4.5. T4 DNA Ligase Market - Germany
- 7.4.5.1. Germany: T4 DNA Ligase Market, by Type, 2019-2032 (USD million)
- 7.4.5.2. Germany: T4 DNA Ligase Market, by Application, 2019-2032 (USD million)
- 7.4.6. T4 DNA Ligase Market - Italy
- 7.4.6.1. Italy: T4 DNA Ligase Market, by Type, 2019-2032 (USD million)
- 7.4.6.2. Italy: T4 DNA Ligase Market, by Application, 2019-2032 (USD million)
- 7.4.7. T4 DNA Ligase Market - Spain
- 7.4.7.1. Spain: T4 DNA Ligase Market, by Type, 2019-2032 (USD million)
- 7.4.7.2. Spain: T4 DNA Ligase Market, by Application, 2019-2032 (USD million)
- 7.4.8. T4 DNA Ligase Market - Netherlands
- 7.4.8.1. Netherlands: T4 DNA Ligase Market, by Type, 2019-2032 (USD million)
- 7.4.8.2. Netherlands: T4 DNA Ligase Market, by Application, 2019-2032 (USD million)
- 7.4.9. T4 DNA Ligase Market - Russia
- 7.4.9.1. Russia: T4 DNA Ligase Market, by Type, 2019-2032 (USD million)
- 7.4.9.2. Russia: T4 DNA Ligase Market, by Application, 2019-2032 (USD million)
- 7.4.10. T4 DNA Ligase Market - Rest of Europe
- 7.4.10.1. Rest of Europe: T4 DNA Ligase Market, by Type, 2019-2032 (USD million)
- 7.4.10.2. Rest of Europe: T4 DNA Ligase Market, by Application, 2019-2032 (USD million)
- 7.5. T4 DNA Ligase Market - Asia Pacific
- 7.5.1. Asia Pacific: T4 DNA Ligase Market, by Type, 2019-2032 (USD million)
- 7.5.2. Asia Pacific: T4 DNA Ligase Market, by Application, 2019-2032 (USD million)
- 7.5.3. T4 DNA Ligase Market - China
- 7.5.3.1. China: T4 DNA Ligase Market, by Type, 2019-2032 (USD million)
- 7.5.3.2. China: T4 DNA Ligase Market, by Application, 2019-2032 (USD million)
- 7.5.4. T4 DNA Ligase Market - India
- 7.5.4.1. India: T4 DNA Ligase Market, by Type, 2019-2032 (USD million)
- 7.5.4.2. India: T4 DNA Ligase Market, by Application, 2019-2032 (USD million)
- 7.5.5. T4 DNA Ligase Market - Malaysia
- 7.5.5.1. Malaysia: T4 DNA Ligase Market, by Type, 2019-2032 (USD million)
- 7.5.5.2. Malaysia: T4 DNA Ligase Market, by Application, 2019-2032 (USD million)
- 7.5.6. T4 DNA Ligase Market - Japan
- 7.5.6.1. Japan: T4 DNA Ligase Market, by Type, 2019-2032 (USD million)
- 7.5.6.2. Japan: T4 DNA Ligase Market, by Application, 2019-2032 (USD million)
- 7.5.7. T4 DNA Ligase Market - Indonesia
- 7.5.7.1. Indonesia: T4 DNA Ligase Market, by Type, 2019-2032 (USD million)
- 7.5.7.2. Indonesia: T4 DNA Ligase Market, by Application, 2019-2032 (USD million)
- 7.5.8. T4 DNA Ligase Market - South Korea
- 7.5.8.1. South Korea: T4 DNA Ligase Market, by Type, 2019-2032 (USD million)
- 7.5.8.2. South Korea: T4 DNA Ligase Market, by Application, 2019-2032 (USD million)
- 7.5.9. T4 DNA Ligase Market - Australia
- 7.5.9.1. Australia: T4 DNA Ligase Market, by Type, 2019-2032 (USD million)
- 7.5.9.2. Australia: T4 DNA Ligase Market, by Application, 2019-2032 (USD million)
- 7.5.10. T4 DNA Ligase Market - Rest of Asia Pacific
- 7.5.10.1. Rest of Asia Pacific: T4 DNA Ligase Market, by Type, 2019-2032 (USD million)
- 7.5.10.2. Rest of Asia Pacific: T4 DNA Ligase Market, by Application, 2019-2032 (USD million)
- 7.6. T4 DNA Ligase Market - Middle East & Africa
- 7.6.1. Middle East & Africa: T4 DNA Ligase Market, by Type, 2019-2032 (USD million)
- 7.6.2. Middle East & Africa: T4 DNA Ligase Market, by Application, 2019-2032 (USD million)
- 7.6.3. T4 DNA Ligase Market - Saudi Arabia
- 7.6.3.1. Saudi Arabia: T4 DNA Ligase Market, by Type, 2019-2032 (USD million)
- 7.6.3.2. Saudi Arabia: T4 DNA Ligase Market, by Application, 2019-2032 (USD million)
- 7.6.4. T4 DNA Ligase Market - UAE
- 7.6.4.1. UAE: T4 DNA Ligase Market, by Type, 2019-2032 (USD million)
- 7.6.4.2. UAE: T4 DNA Ligase Market, by Application, 2019-2032 (USD million)
- 7.6.5. T4 DNA Ligase Market - Israel
- 7.6.5.1. Israel: T4 DNA Ligase Market, by Type, 2019-2032 (USD million)
- 7.6.5.2. Israel: T4 DNA Ligase Market, by Application, 2019-2032 (USD million)
- 7.6.6. T4 DNA Ligase Market - South Africa
- 7.6.6.1. South Africa: T4 DNA Ligase Market, by Type, 2019-2032 (USD million)
- 7.6.6.2. South Africa: T4 DNA Ligase Market, by Application, 2019-2032 (USD million)
- 7.6.7. T4 DNA Ligase Market - Rest of Middle East & Africa
- 7.6.7.1. Rest of Middle East & Africa: T4 DNA Ligase Market, by Type, 2019-2032 (USD million)
- 7.6.7.2. Rest of Middle East & Africa: T4 DNA Ligase Market, by Application, 2019-2032 (USD million)
- 7.7. T4 DNA Ligase Market - Latin America
- 7.7.1. Latin America: T4 DNA Ligase Market, by Type, 2019-2032 (USD million)
- 7.7.2. Latin America: T4 DNA Ligase Market, by Application, 2019-2032 (USD million)
- 7.7.3. T4 DNA Ligase Market - Mexico
- 7.7.3.1. Mexico: T4 DNA Ligase Market, by Type, 2019-2032 (USD million)
- 7.7.3.2. Mexico: T4 DNA Ligase Market, by Application, 2019-2032 (USD million)
- 7.7.4. T4 DNA Ligase Market - Brazil
- 7.7.4.1. Brazil: T4 DNA Ligase Market, by Type, 2019-2032 (USD million)
- 7.7.4.2. Brazil: T4 DNA Ligase Market, by Application, 2019-2032 (USD million)
- 7.7.5. T4 DNA Ligase Market - Argentina
- 7.7.5.1. Argentina: T4 DNA Ligase Market, by Type, 2019-2032 (USD million)
- 7.7.5.2. Argentina: T4 DNA Ligase Market, by Application, 2019-2032 (USD million)
- 7.7.6. T4 DNA Ligase Market - Rest of Latin America
- 7.7.6.1. Rest of Latin America: T4 DNA Ligase Market, by Type, 2019-2032 (USD million)
- 7.7.6.2. Rest of Latin America: T4 DNA Ligase Market, by Application, 2019-2032 (USD million)
8. Competitive Landscape
- 8.1. Expansion and Acquisition Analysis
- 8.1.1. Expansion
- 8.1.2. Acquisitions
- 8.2. Partnerships/Collaborations/Agreements/Exhibitions
9. Company Profiles
- 9.1. Thermo Fisher Scientific
- 9.1.1. Company Overview
- 9.1.2. Financial Performance
- 9.1.3. Product Benchmarking
- 9.1.4. Recent Development
- 9.2. New England Biolabs
- 9.2.1. Company Overview
- 9.2.2. Financial Performance
- 9.2.3. Product Benchmarking
- 9.2.4. Recent Development
- 9.3. Merck KGaA
- 9.3.1. Company Overview
- 9.3.2. Financial Performance
- 9.3.3. Product Benchmarking
- 9.3.4. Recent Development
- 9.4. Promega Corporation
- 9.4.1. Company Overview
- 9.4.2. Financial Performance
- 9.4.3. Product Benchmarking
- 9.4.4. Recent Development
- 9.5. Takara Bio Inc.
- 9.5.1. Company Overview
- 9.5.2. Financial Performance
- 9.5.3. Product Benchmarking
- 9.5.4. Recent Development
- 9.6. Agilent Technologies
- 9.6.1. Company Overview
- 9.6.2. Financial Performance
- 9.6.3. Product Benchmarking
- 9.6.4. Recent Development
- 9.7. Roche Diagnostics
- 9.7.1. Company Overview
- 9.7.2. Financial Performance
- 9.7.3. Product Benchmarking
- 9.7.4. Recent Development
- 9.8. Qiagen N.V.
- 9.8.1. Company Overview
- 9.8.2. Financial Performance
- 9.8.3. Product Benchmarking
- 9.8.4. Recent Development
- 9.9. Bio-Rad Laboratories
- 9.9.1. Company Overview
- 9.9.2. Financial Performance
- 9.9.3. Product Benchmarking
- 9.9.4. Recent Development
- 9.10. Illumina Inc.
- 9.10.1. Company Overview
- 9.10.2. Financial Performance
- 9.10.3. Product Benchmarking
- 9.10.4. Recent Development
- 9.11. GenScript Biotech Corporation
- 9.11.1. Company Overview
- 9.11.2. Financial Performance
- 9.11.3. Product Benchmarking
- 9.11.4. Recent Development
- 9.12. Lucigen Corporation
- 9.12.1. Company Overview
- 9.12.2. Financial Performance
- 9.12.3. Product Benchmarking
- 9.12.4. Recent Development
- 9.13. Eurofins Scientific
- 9.13.1. Company Overview
- 9.13.2. Financial Performance
- 9.13.3. Product Benchmarking
- 9.13.4. Recent Development
- 9.14. Jena Bioscience.
- 9.14.1. Company Overview
- 9.14.2. Financial Performance
- 9.14.3. Product Benchmarking
- 9.14.4. Recent Development
- 9.15. Bioline.
- 9.15.1. Company Overview
- 9.15.2. Financial Performance
- 9.15.3. Product Benchmarking
- 9.15.4. Recent Development
